Stonebridge Capital Advisors LLC Amarin Corp Plcuk Transaction History

Stonebridge Capital Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.85 - $3.73 $12,540 - $16,412	-4,400 Reduced 81.48%	1,000 $3,000
Q1 2021 May 14, 2021	BUY	$5.03 - $8.8 $27,162 - $47,520	5,400 New	5,400 $34,000
Q3 2020 Nov 18, 2020	SELL	$3.64 - $7.76 $19,656 - $41,904	-5,400 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$4.78 - $8.26 $2,390 - $4,130	-500 Reduced 8.47%	5,400 $37,000
Q1 2020 May 15, 2020	BUY	$4.0 - $21.53 $21,600 - $116,262	5,400 Added 1080.0%	5,900 $24,000
Q4 2019 Feb 14, 2020	BUY	$13.94 - $24.12 $6,970 - $12,060	500 New	500 $11,000

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $254M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Stonebridge Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Stonebridge Capital Advisors LLC with notifications on news.